Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-102963
Filing Date
2025-08-05
Accepted
2025-08-05 16:00:22
Documents
61
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q glto-20250630.htm   iXBRL 10-Q 1872145
2 EX-31.1 glto-ex31_1.htm EX-31.1 20808
3 EX-31.2 glto-ex31_2.htm EX-31.2 20846
4 EX-32.1 glto-ex32_1.htm EX-32.1 17609
  Complete submission text file 0000950170-25-102963.txt   6595768

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT glto-20250630.xsd EX-101.SCH 931945
64 EXTRACTED XBRL INSTANCE DOCUMENT glto-20250630_htm.xml XML 984469
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)